Prognostic impact of diabetes mellitus and hypertension for mid-term outcome of patients with acute myocardial infarction who underwent percutaneous coronary intervention

Journal of Cardiology

Volumn 60, Issue 4, 2012, Pages 257-263

  Lee, Min Goo ^a   Jeong, Myung Ho ^a   Lee, Ki Hong ^a   Park, Keun Ho ^a   Sim, Doo Sun ^a   Yoon, Hyun Ju ^a   Yoon, Nam Sik ^a   Kim, Kye Hun ^a   Park, Hyung Wook ^a   Hong, Young Joon ^a   Kim, Ju Han ^a   Ahn, Youngkeun ^a   Cho, Jeong Gwan ^a   Park, Jong Chun ^a   Kang, Jung Chaee ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

Diabetes mellitus; Hypertension; Myocardial infarction

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; CORONARY ARTERY RECANALIZATION; DIABETES MELLITUS; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; RECURRENT DISEASE;

AGED; CORONARY ANGIOGRAPHY; DIABETES COMPLICATIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; TREATMENT OUTCOME;

EID: 84866547628     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2012.06.003     Document Type: Article

References (37)

1. Epstein M., Sowers J.R. Diabetes mellitus and hypertension. Hypertension 1992, 19:403-418.
2. Psaty B.M., Furberg C.D., Kuller L.H., Cushman M., Savage P.J., Levine D., O'Leary D.H., Bryan R.N., Anderson M., Lumley T. Association between blood pressure level and the risk of myocardial infarction, stroke and total mortality: the cardiovascular health study. Arch Intern Med 2001, 161:1183-1192.
3. Teuscher A., Egger M., Herman J.B. Diabetes and hypertension: blood pressure in clinical diabetic patients and a control population. Arch Intern Med 1989, 149:1942-1945.
4. Bonora E., Kiechl S., Willeit J., Oberhollenzer F., Egger G., Meigs J.B., Bonadonna R.C., Muggeo M. Population-based incidence rates and risk factors for type 2 diabetes in white individuals: the Bruneck study. Diabetes 2004, 53:1782-1789.
5. Jensen L.O., Maeng M., Thayssen P., Tilsted H.H., Terkelsen C.J., Kaltoft A., Lassen J.F., Hansen K.N., Ravkilde J., Christiansen E.H., Madsen M., Sørensen H.T., Thuesen L. Influence of diabetes mellitus on clinical outcomes following primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction. Am J Cardiol 2012, 109:629-635.
6. Pitsavos C., Kourlaba G., Panagiotakos D.B., Stefanadis C. Characteristics and in-hospital mortality of diabetics and nondiabetics with an acute coronary syndrome: the GREECS study. Clin Cardiol 2007, 30:239-244.
7. Saydah S.H., Fradkin J., Cowie C.C. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 2004, 291:335-342.
8. Mak K.H., Moliterno D.J., Granger C.B., Miller D.P., White H.D., Wilcox R.G., Califf R.M., Topol E.J. Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. J Am Coll Cardiol 1997, 30:171-179. the GUSTO-I Investigators.
9. Lee K.L., Woodlief L.H., Topol E.J., Weaver W.D., Betriu A., Col J., Simoons M., Aylward P., Van de Werf F., Califf R.M. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from the international trial of 41,021 patients. Circulation 1995, 91:1659-1668. the GUSTO-I Investigators.
10. Herlitz J., Bang A., Karlson B.W. Five year prognosis after acute myocardial infarction in relation to a history of hypertension. J Hypertens 1996, 9:70-76.
11. Lingman M., Herlitz J., Bergfeldt L., Karlsson T., Caidahl K., Hartford M. Acute coronary syndrome - the prognostic impact of hypertension, diabetes and its combination on long-term outcome. Int J Cardiol 2009, 137:29-36.
12. Thygesen K., Alpert J.S., White H.D. Universal definition of myocardial infarction. J Am Coll Cardiol 2007, 50:2173-2195.
13. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2010, 33(Suppl. 1):S62.
14. Levey A.S., Coresh J., Greene T., Marsh J., Stevens L.A., Kusek J.W., Van Lente F. Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem 2007, 53:766-772. Chronic Kidney Disease Epidemiology Collaboration.
15. Cutlip D.E., Windecker S., Mehran R., Boam A., Cohen D.J., van Es G.A., Steg P.G., Morel M.A., Mauri L., Vranckx P., McFadden E., Lansky A., Hamon M., Krucoff M.W., Serruys P.W., et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007, 115:2344-2351.
16. Pastor-Barriuso R., Banegas J.R., Damián J., Appel L.J., Guallar E. Systolic blood pressure, diastolic blood pressure, and pulse pressure: an evaluation of their joint effect on mortality. Ann Intern Med 2003, 139:731-739.
17. Richards A.M., Nicholls M.G., Troughton R.W., Lainchbury J.G., Elliott J., Frampton C., Espiner E.A., Crozier I.G., Yandle T.G., Turner J. Antecedent hypertension and heart failure after myocardial infarction. J Am Coll Cardiol 2002, 39:1182-1188.
18. Thune J.J., Signorovitch J., Kober L., Velazquez E.J., McMurray J.J., Califf R.M., Maggioni A.P., Rouleau J.L., Howlett J., Zelenkofske S., Pfeffer M.A., Solomon S.D. Effect of antecedent hypertension and follow-up blood pressure on outcomes after high-risk myocardial infarction. Hypertension 2008, 51:48-54.
19. Kenchaiah S., Davis B.R., Braunwald E., Rouleau J.L., Dagenais G.R., Sussex B., Steingart R.M., Brown E.J., Lamas G.A., Gordon D., Bernstein V., Pfeffer M.A. Survival and Ventricular Enlargement Trial. Antecedent hypertension and the effect of captopril on the risk of adverse cardiovascular outcomes after acute myocardial infarction with left ventricular systolic dysfunction: insights from the Survival and Ventricular Enlargement Trial. Am Heart J 2004, 148:356-364.
20. Brownlee M. Glycation and diabetic complications. Diabetes 1994, 43:836-841.
21. Yamagishi S. Cardiovascular disease in recent onset diabetes mellitus. J Cardiol 2011, 57:257-262.
22. Laakso M., Lehto S. Epidemiology of macrovascular disease in diabetes. Diabetes Rev 1997, 5:294-315.
23. Isomaa B., Almgren P., Tuomi T., Forsén B., Lahti K., Nissén M., Taskinen M.R., Groop L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001, 24:683-689.
24. Washio M., Sasazuki S., Kodama H., Yoshimasu K., Liu Y., Tanaka K., Tokunaga S., Kono P.S., Arai H., Koyanagi S., Hiyamuta K., Doi Y., Kawano M.T., Nakagaki M.O., Takada K., et al. Role of hypertension, dyslipidemia and diabetes mellitus in the development of coronary atherosclerosis in Japan. Circ J 2001, 65:731-737.
25. Grossman E., Messereli F.H. Diabetic and hypertensive heart disease. Ann Intern Med 1996, 125:304-310.
26. Arora G.D., Reeves W.C., Movahed A. Alteration of coronary perfusion reserve in hypertensive patients with diabetes. J Hum Hypertens 1994, 8:51-57.
27. Mizuguchi Y., Oishi Y., Miyoshi H., Iuchi A., Nagase N., Oki T. Concentric left ventricular hypertrophy brings deterioration of systolic longitudinal, circumferential, and radial myocardial deformation in hypertensive patients with preserved left ventricular pump function. J Cardiol 2010, 55:23-33.
28. Cho K.I., Park J.H., Lee C.K., Kim S.H., Ahn J.M., Kim S., Kim T.I. Isolated and combined influences of diabetes and hypertension on the myocardial function and geometry. Korean Circ J 2006, 36:411-417.
29. Eagle K.A., Goodman S.G., Avezurn A., Budaj A., Sullivan C.M., López-Sendón J., the GRACE Investigators Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE). Lancet 2002, 359:373-377.
30. Hsu L.F., Mak K.H., Lau K.W., Sim L.L., Chan C., Koh T.H., Chuah S.C., Kam R., Ding Z.P., Teo W.S., Lim Y.L. Clinical outcomes of patients with diabetes mellitus and acute myocardial infarction treated with primary angioplasty or fibrinolysis. Heart 2002, 88:260-265.
31. Franklin K., Goldberg R.J., Spencer F., Klein W., Budaj A., Brieger D., Marre M., Steg P.G., Gowda N., Gore J.M. Implications of diabetes in patients with acute coronary syndromes. The Global Registry of Acute Coronary Events. Arch Intern Med 2004, 164:1457-1463. the GRACE Investigators.
32. Levantesi G., Macchia A., Marfisi R., Franzosi M.G., Maggioni A.P., Nicolosi G.L., Schweiger C., Tavazzi L., Tognoni G., Valagussa F., Marchioli R. Metabolic syndrome and risk of cardiovascular events after myocardial infarction. J Am Coll Cardiol 2005, 46:277-283. GISSI-Prevenzione Investigators.
33. Aronson D., Rayfield E.J., Chesebro J.H. Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction. Ann Intern Med 2007, 126:296-306.
34. Calcerá-Tomás J., Melgarejo-Moreno A., García-Alberola A., Rodríguez-García P., Lozano-Martínez J., Martínez-Hernández J., Martínez-Fernández S. Prognostic significance of diabetes in acute myocardial infarction: are the differences linked to female gender?. Int J Cardiol 1999, 69:289-298.
35. Nakamura T., Ako J., Kadowaki T., Funayama H., Sugawara Y., Kubo N., Momomura S. Impact of acute hyperglycemia during primary stent implantation in patients with ST-elevation myocardial infarction. J Cardiol 2009, 53:272-277.
36. Lingman M., Albertsson P., Herlitz J., Bergfeldt L., Lagerqvist B. The impact of hypertension and diabetes on outcome in patients undergoing percutaneous coronary intervention. Am J Med 2011, 124:265-275.
37. Lee M.G., Jeong M.H., Ahn Y., Chae S.C., Hur S.H., Hong T.J., Kim Y.J., Seong I.W., Chae J.K., Rhew J.Y., Chae I.H., Cho M.C., Bae J.H., Rha S.W., Kim C.J., et al. Comparison of clinical outcomes following acute myocardial infarction in hypertensive patients with or without diabetes. Korean Circ J 2009, 36:243-250.